drugset / Trial / NCT03811912
Efficacy and Tolerability Study of Two Dose Regimens of CTP-543 in Adults With Alopecia Areata
RandomizedParallel-groupTriple-blindTreatment
Summary
This study will evaluate the efficacy and tolerability of once-daily versus twice-daily dosing of CTP-543, in adult patients with chronic, moderate to severe alopecia areata.
Timeline
- Start
- 2019-03-21
- Primary completion
- 2019-11-21
- Completion
- 2019-11-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CTP-543 | Unknown | 8 mg | — |
| Subject | CTP-543 | Unknown | 16 mg | — |